Literature DB >> 25054672

Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population.

Adam Linder1, Daphne Guh, John H Boyd, Keith R Walley, Aslam H Anis, James A Russell.   

Abstract

OBJECTIVES: Long-term (1- to 10-year) outcomes after severe sepsis in previously healthy persons are unknown. We aimed to determine the 1- to 10-year mortality rates of previously healthy patients with severe sepsis and compare these to mortality rates of patients with nonseptic critical illness and the general population.
DESIGN: A prospective cohort study of 2,289 patients from one mixed medical-surgical ICU and one cardiovascular surgery ICU. Age- and gender-comparable general British Columbia population was used as comparison. Patients were followed from the date of admission to the ICU to January 31, 2013. Provincial vital statistics were used to determine the patients' date of death. For the general population comparison, expected survival was obtained from life tables of the population of British Columbia, Canada.
SETTING: A quaternary-level provincial referral hospital in Vancouver, British Columbia, Canada. PATIENTS: Two thousand two hundred eighty-nine patients from one mixed medical-surgical ICU and one cardiovascular surgery ICU. Age- and gender-comparable general British Columbia population was used for comparison.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Patients with severe sepsis without comorbidities had higher mortality from 1 to 10 years than general British Columbia population (p < 0.01). Younger patients with severe sepsis (< 60 yr) had the worst 1- to 5-year and 5- to 10-year mortality (hazard ratio [95% CI], 17.8 [13.4-24.8] and 6.0 [4-9]) compared with the general population. Patients with severe sepsis had significantly poorer 1- to 10-year mortality rates (30.5%) compared with patients with nonseptic critical illness (22.1%) and patients who have undergone cardiovascular surgery (15.9%). Patients with sepsis had higher mortality rates from 1-5 years and 5-10 years than the general British Columbia population (hazard ratio [95% CI], 4.5 [2.2-9.1] and 2.2 [0.9-14.7]).
CONCLUSIONS: Previously healthy patients suffering an episode of severe sepsis have increased long-term mortality compared with patients with nonseptic critical illness and a general population.

Entities:  

Mesh:

Year:  2014        PMID: 25054672     DOI: 10.1097/CCM.0000000000000503

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  26 in total

1.  Long term mortality following sepsis.

Authors:  Patrick John Kennelly; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2016-10

2.  Recent Anti-Microbial Exposure Is Associated with More Complications after Elective Surgery.

Authors:  Christopher A Guidry; Puja M Shah; Zachary C Dietch; Nathan R Elwood; Elizabeth D Krebs; J Hunter Mehaffey; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2018-06-08       Impact factor: 2.150

3.  Getting down to the real question: effects of transfusion triggers on long-term survival and quality of life following septic shock.

Authors:  Martin W Dünser; James A Russell
Journal:  Intensive Care Med       Date:  2016-09-30       Impact factor: 17.440

Review 4.  Advances in the understanding and treatment of sepsis-induced immunosuppression.

Authors:  Fabienne Venet; Guillaume Monneret
Journal:  Nat Rev Nephrol       Date:  2017-12-11       Impact factor: 28.314

5.  The Specific Organism: Not Bacterial Gram Type: Drives the Inflammatory Response in Septic Shock.

Authors:  Adam Linder; Chris D Fjell; Malin Inghammar; Joseph Hsu; Keith R Walley; John H Boyd; James A Russell
Journal:  J Innate Immun       Date:  2019-06-26       Impact factor: 7.349

Review 6.  Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19.

Authors:  Ivo Udovicic; Ivan Stanojevic; Dragan Djordjevic; Snjezana Zeba; Goran Rondovic; Tanja Abazovic; Srdjan Lazic; Danilo Vojvodic; Kendrick To; Dzihan Abazovic; Wasim Khan; Maja Surbatovic
Journal:  J Clin Med       Date:  2021-12-12       Impact factor: 4.241

7.  Prevalence and Outcomes of Previously Healthy Adults Among Patients Hospitalized With Community-Onset Sepsis.

Authors:  Mohammad Alrawashdeh; Michael Klompas; Steven Q Simpson; Sameer S Kadri; Russell Poland; Jeffrey S Guy; Jonathan B Perlin; Chanu Rhee
Journal:  Chest       Date:  2022-01-20       Impact factor: 10.262

8.  Protocol for a two-arm pragmatic stepped-wedge hybrid effectiveness-implementation trial evaluating Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship (ENCOMPASS).

Authors:  Marc Kowalkowski; Tara Eaton; Andrew McWilliams; Hazel Tapp; Aleta Rios; Stephanie Murphy; Ryan Burns; Bella Gutnik; Katherine O'Hare; Lewis McCurdy; Michael Dulin; Christopher Blanchette; Shih-Hsiung Chou; Scott Halpern; Derek C Angus; Stephanie P Taylor
Journal:  BMC Health Serv Res       Date:  2021-06-02       Impact factor: 2.655

Review 9.  Evidence for a causal link between sepsis and long-term mortality: a systematic review of epidemiologic studies.

Authors:  Manu Shankar-Hari; Michael Ambler; Viyaasan Mahalingasivam; Andrew Jones; Kathryn Rowan; Gordon D Rubenfeld
Journal:  Crit Care       Date:  2016-04-13       Impact factor: 9.097

Review 10.  Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure.

Authors:  Alexandre Mebazaa; Pierre François Laterre; James A Russell; Andreas Bergmann; Luciano Gattinoni; Etienne Gayat; Michael O Harhay; Oliver Hartmann; Frauke Hein; Anne Louise Kjolbye; Matthieu Legrand; Roger J Lewis; John C Marshall; Gernot Marx; Peter Radermacher; Mathias Schroedter; Paul Scigalla; Wendy Gattis Stough; Joachim Struck; Greet Van den Berghe; Mehmet Birhan Yilmaz; Derek C Angus
Journal:  J Intensive Care       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.